-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, Cidara Therapeutics Prices Upsized Public Offering Of 7,954,546 Shares At $44 Per Share To Raise $350M

Benzinga·06/25/2025 06:42:24
Listen to the news

The gross proceeds to Cidara from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $350.0 million.